Home > Publications database > Novel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer. > print

001     291774
005     20250514132633.0
024 7 _ |a 10.1002/ctm2.1776
|2 doi
024 7 _ |a pmid:39032146
|2 pmid
024 7 _ |a pmc:PMC11260171
|2 pmc
037 _ _ |a DKFZ-2024-01510
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Jäger, Dirk
|0 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
|b 0
|e First author
|u dkfz
245 _ _ |a Novel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer.
260 _ _ |a Hoboken, NJ
|c 2024
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1721656455_17462
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D120#LA:D420#
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Receptors, Chimeric Antigen
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Breast Neoplasms: immunology
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Receptors, Chimeric Antigen: therapeutic use
|2 MeSH
650 _ 2 |a Receptors, Chimeric Antigen: immunology
|2 MeSH
650 _ 2 |a Treatment Outcome
|2 MeSH
700 1 _ |a Berger, Aileen
|0 P:(DE-He78)13dec090ab995ddbfa602b546eace8b0
|b 1
|e First author
700 1 _ |a Tuch, Alexandra
|0 P:(DE-He78)5ab3e75a5a7c0a8d804f9833a1152067
|b 2
|u dkfz
700 1 _ |a Luckner-Minden, Claudia
|b 3
700 1 _ |a Eurich, Rosa
|b 4
700 1 _ |a Hlevnjak, Mario
|b 5
700 1 _ |a Schneeweiss, Andreas
|b 6
700 1 _ |a Lichter, Peter
|0 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
|b 7
|u dkfz
700 1 _ |a Aulmann, Sebastian
|b 8
700 1 _ |a Heussel, Claus-Peter
|b 9
700 1 _ |a Fremd, Carlo
|b 10
700 1 _ |a Harbottle, Richard
|0 P:(DE-He78)15dff5647002b4dcfe892b251cd14b62
|b 11
|u dkfz
700 1 _ |a Zörnig, Inka
|b 12
700 1 _ |a Schmidt, Patrick
|0 P:(DE-He78)0a9ff2c74a3fef06f552be5bb95bfd2d
|b 13
|e Last author
|u dkfz
773 _ _ |a 10.1002/ctm2.1776
|g Vol. 14, no. 7, p. e1776
|0 PERI:(DE-600)2697013-2
|n 7
|p e1776
|t Clinical and translational medicine
|v 14
|y 2024
|x 2001-1326
856 4 _ |u https://inrepo02.dkfz.de/record/291774/files/Clinical%20Translational%20Med%20-%202024%20-%20J%C3%A4ger%20-%20Novel%20chimeric%20antigen%20receptors%20for%20the%20effective%20and%20safe%20treatment%20of.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/291774/files/Clinical%20Translational%20Med%20-%202024%20-%20J%C3%A4ger%20-%20Novel%20chimeric%20antigen%20receptors%20for%20the%20effective%20and%20safe%20treatment%20of.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:inrepo02.dkfz.de:291774
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)13dec090ab995ddbfa602b546eace8b0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)5ab3e75a5a7c0a8d804f9833a1152067
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)e13b4363c5fe858044ef8a39c02c870c
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)15dff5647002b4dcfe892b251cd14b62
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)0a9ff2c74a3fef06f552be5bb95bfd2d
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN TRANSL MED : 2022
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-06-08T15:16:46Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-06-08T15:16:46Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2020-06-08T15:16:46Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-06-08T15:16:46Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-26
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-26
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-26
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-26
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b CLIN TRANSL MED : 2022
|d 2023-10-26
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-10-26
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-10-26
920 2 _ |0 I:(DE-He78)D420-20160331
|k D420
|l DNA-Vektoren
|x 0
920 1 _ |0 I:(DE-He78)D120-20160331
|k D120
|l D120 Angewandte Tumor-Immunität
|x 0
920 1 _ |0 I:(DE-He78)B060-20160331
|k B060
|l B060 Molekulare Genetik
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)D420-20160331
|k D420
|l DNA-Vektoren
|x 3
920 1 _ |0 I:(DE-He78)D210-20160331
|k D210
|l GMP-Einheit Zelluläre Therapie
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D120-20160331
980 _ _ |a I:(DE-He78)B060-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)D420-20160331
980 _ _ |a I:(DE-He78)D210-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21